Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adapting Drug Approval Pathways for Bacteriophage-Based Therapeutics

2 Aug 2016

Abstract excerpt

The global rise of multi-drug resistant bacteria has resulted in the notion that an "antibiotic apocalypse" is fast approaching. This has led to a number of well publicized calls for global funding initiatives to develop new antibacterial agents. The long clinical history of phage therapy in Eastern Europe, combined with more recent in vitro and in vivo success, demonstrates the potential for whole phage or phage...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteriophages and microbial interactions
Share to Clostridium difficile and Clostridium perfringens research
Share to Monoclonal and Polyclonal Antibodies Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27536293
DOI: 10.3389/fmicb.2016.01209

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adapting Drug Approval Pathways for Bacteriophage-Based TherapeuticsPMID 27536293Read ↗

Phage Therapy in the Twenty-First Century: Facing the Decline of the Antibiotic Era; Is It Finally Time for the Age of the Phage?Semantic proximity Read ↗

The Preclinical and Clinical Progress of Bacteriophages and Their Lytic Enzymes: The Parts are Easier than the WholeSemantic proximity Read ↗

Phage therapeutics: from promises to practices and prospectivesSemantic proximity Read ↗

Virological and Pharmaceutical Properties of Clinically Relevant PhagesSemantic proximity Read ↗

Current State of Compassionate Phage TherapySemantic proximity Read ↗

What are the limitations on the wider therapeutic use of phage?Semantic proximity Read ↗

A review on re-emerging bacteriophage therapy in the era of XDRSemantic proximity Read ↗

Phage and Endolysin Therapy Against Antibiotics Resistant Bacteria: From Bench to BedsideSemantic proximity Read ↗

Bacteriophage as an Antibacterial Agent: A Patent PerspectiveSemantic proximity Read ↗

The Future of Clinical Phage Therapy in the United KingdomSemantic proximity Read ↗

Can Bacteriophages Replace Antibiotics?Semantic proximity Read ↗

Phage Therapy: A Different Approach to Fight Bacterial InfectionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.